Fluazaindolizine Patent Landscape Analysis

Fluazaindolizine is a nematicide developed by Corteva Agriscience, commercialised through the Salibro® / Reklemel™ brand.

The retained landscape covers 19 patent families across 14 consolidated owner groups. Two-active combination is the thickest protection layer (15 families), with manufacturing route and intermediates providing additional constraint.

8 of the 19 retained families carry a grant or national pending reading. 12 families are held by China-based applicants; one live family has a nominal term ending within five years. Position as at October 2026.

This 30-page report provides a seven-part analysis covering ownership, active-ingredient manufacture, single-active formulation, fixed-dose mixtures, national market entry and owner profiles, with route-level remaining-space notes and an appendix owner directory.

Not a freedom-to-operate opinion.